DocGo’s (DCGO) Buy Rating Reiterated at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a report released on Wednesday, Benzinga reports.

A number of other brokerages have also recently commented on DCGO. Canaccord Genuity Group reiterated a “hold” rating and issued a $1.00 target price on shares of DocGo in a research report on Tuesday, August 18th. Weiss Ratings restated a “sell (e+)” rating on shares of DocGo in a report on Monday, September 14th. Three analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, DocGo presently has a consensus rating of “Hold” and a consensus target price of $2.38.

DocGo Price Performance

Shares of DCGO opened at $0.37 on Wednesday. The firm’s 50 day simple moving average is $0.48 and its 200 day simple moving average is $0.56. The company has a market capitalization of $36.41 million, a P/E ratio of -0.19 and a beta of 0.94. DocGo has a 1-year low of $0.31 and a 1-year high of $1.65.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). The business had revenue of $73.42 million during the quarter, compared to the consensus estimate of $75.35 million. DocGo had a negative return on equity of 40.42% and a negative net margin of 65.29%. On average, equities analysts anticipate that DocGo will post -0.22 earnings per share for the current year.

Hedge Funds Weigh In On DocGo

A number of hedge funds have recently bought and sold shares of the company. S Squared Technology LLC bought a new position in DocGo in the 2nd quarter worth about $1,060,725. Renaissance Technologies LLC lifted its stake in DocGo by 167.1% during the 1st quarter. Renaissance Technologies LLC now owns 1,510,361 shares of the company’s stock valued at $950,000 after acquiring an additional 944,826 shares during the period. BlackRock Inc. bought a new position in DocGo during the 2nd quarter valued at about $750,000. Isthmus Partners LLC increased its position in shares of DocGo by 14.0% during the 1st quarter. Isthmus Partners LLC now owns 1,013,056 shares of the company’s stock valued at $637,000 after purchasing an additional 124,211 shares during the last quarter. Finally, GSA Capital Partners LLP purchased a new stake in shares of DocGo during the 2nd quarter valued at about $517,000. Institutional investors own 56.44% of the company’s stock.

About DocGo

DocGo Inc (NASDAQ: DCGO) is a healthcare services and technology company that delivers medical care and transportation outside traditional clinical settings. Its platform combines mobile clinical services, technology-enabled care coordination and non-emergency medical transportation to help healthcare providers, government agencies, insurers and employers serve patients in their homes and communities.

The company’s services include ambulance and non-emergency medical transportation, mobile primary and urgent care, remote patient monitoring, diagnostic testing, vaccination programs and community-based healthcare.